Sabrina Martinez, Christian N Nouryan, Myia S Williams, Vidhi H Patel, Paulina Barbero, Valeria Correa Gomez, Jose Marino, Nicole Goris, Edgardo Cigaran, Dilcia Granville, Lawrence F Murray, Yael T Harris, Alyson Myers, Josephine Guzman, Amgad N Makaryus, Samy I McFarlane, Roman Zeltser, Maria Pena, Cristina Sison, Martin L Lesser, Myriam Kline, Ralph Joseph DiClemente, Renee Pekmezaris
BACKGROUND: The Hispanic/Latino population has greater risk (estimated >50%) of developing type 2 diabetes (T2D) and developing it at a younger age. The American Diabetes Association estimates costs of diagnosed diabetes in 2017 was $327 billion; with medical costs 2.3x higher than patients without diabetes. The purpose of this manuscript is to describe the methodology utilized in a randomized controlled trial aimed at evaluating the efficacy of a diabetes telemanagement (DTM) program for Hispanic/Latino patients with T2D...
2024: Front Clin Diabetes Healthc